These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30250936)

  • 1. The genetics of retinopathy of prematurity: a model for neovascular retinal disease.
    Swan R; Kim SJ; Campbell JP; Paul Chan RV; Sonmez K; Taylor KD; Li X; Chen YI; Rotter JI; Simmons C; Chiang MF;
    Ophthalmol Retina; 2018 Sep; 2(9):949-962. PubMed ID: 30250936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to advanced retinopathy of prematurity (ROP).
    Shastry BS
    J Biomed Sci; 2010 Aug; 17(1):69. PubMed ID: 20738858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinopathy of prematurity: contribution of inflammatory and genetic factors.
    Fevereiro-Martins M; Guimarães H; Marques-Neves C; Bicho M
    Mol Cell Biochem; 2022 Jun; 477(6):1739-1763. PubMed ID: 35262882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Narrative Review on Managing Retinopathy of Prematurity: Insights Into Pathogenesis, Screening, and Treatment Strategies.
    Bishnoi K; Prasad R; Upadhyay T; Mathurkar S
    Cureus; 2024 Mar; 16(3):e56168. PubMed ID: 38618439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and genetic basis for retinopathy of prematurity.
    Csak K; Szabo V; Szabo A; Vannay A
    Front Biosci; 2006 Jan; 11():908-20. PubMed ID: 16146781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants.
    Hartnett ME; Morrison MA; Smith S; Yanovitch TL; Young TL; Colaizy T; Momany A; Dagle J; Carlo WA; Clark EA; Page G; Murray J; DeAngelis MM; Cotten CM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6194-203. PubMed ID: 25118269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge.
    Cavallaro G; Filippi L; Bagnoli P; La Marca G; Cristofori G; Raffaeli G; Padrini L; Araimo G; Fumagalli M; Groppo M; Dal Monte M; Osnaghi S; Fiorini P; Mosca F
    Acta Ophthalmol; 2014 Feb; 92(1):2-20. PubMed ID: 23617889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinopathy of prematurity: a review of risk factors and their clinical significance.
    Kim SJ; Port AD; Swan R; Campbell JP; Chan RVP; Chiang MF
    Surv Ophthalmol; 2018; 63(5):618-637. PubMed ID: 29679617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progress of prophylactic treatment in retinopathy of prematurity.
    Zhang HB; Wang XD; Xu K; Li XG
    Int J Ophthalmol; 2018; 11(5):858-873. PubMed ID: 29862189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity.
    Lloyd J; Askie L; Smith J; Tarnow-Mordi W
    Cochrane Database Syst Rev; 2003; 2003(2):CD003482. PubMed ID: 12804470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
    Huang ZN; Yin DM; Huang DR; Liang SX
    Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early light reduction for preventing retinopathy of prematurity in very low birth weight infants.
    Jorge EC; Jorge EN; El Dib RP
    Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD000122. PubMed ID: 23922202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-1 and retinopathy of prematurity in the preterm infant.
    Smith LE
    Biol Neonate; 2005; 88(3):237-44. PubMed ID: 16210846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes.
    Kim SJ; Sonmez K; Swan R; Campbell JP; Ostmo S; Chan RVP; Nagiel A; Drenser KA; Berrocal AM; Horowitz JD; Li X; Chen YI; Taylor KD; Simmons C; Rotter JI; Chiang MF;
    Sci Rep; 2021 Mar; 11(1):4966. PubMed ID: 33654115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries.
    Dogra MR; Vinekar A
    Pediatric Health Med Ther; 2023; 14():59-69. PubMed ID: 36814935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Study of the Demographic Profile, Screening, and Management of Patients Visiting a Retinopathy of Prematurity Clinic.
    Mushtaq I; Agrawal T; Bhavsar D; Choudhary S; Bakare PN
    Cureus; 2024 Apr; 16(4):e58305. PubMed ID: 38752079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin is not a risk factor for severe retinopathy of prematurity among high risk preterm infants.
    Bui KCT; Ellenhorn N; Abbasi A; Villosis MFB; Nguyen M; Truong H; Watson T; Buchanan J; Chen Q
    Early Hum Dev; 2021 Oct; 161():105440. PubMed ID: 34407495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran.
    Abrishami M; Maemori GA; Boskabadi H; Yaeghobi Z; Mafi-Nejad S; Abrishami M
    Iran Red Crescent Med J; 2013 Mar; 15(3):229-33. PubMed ID: 23984003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.